Final answer:
The statement is true. Second-generation sulfonylureas have several advantages over first-generation sulfonylureas, including the fact that they interact with more protein-bound drugs.
Step-by-step explanation:
The statement is true. Second-generation sulfonylureas do have several advantages over first-generation sulfonylureas, one of which is that they interact with more protein-bound drugs. Sulfonylureas are a class of drugs that stimulate the beta cells of the pancreas to secrete insulin, which helps lower blood glucose levels. Gliclazide, the drug prescribed to Arya, is a second-generation sulfonylurea.
Second-generation sulfonylureas are more selective in their mechanism of action compared to first-generation sulfonylureas. One of the advantages of their selectivity is that they have higher protein-binding affinity, meaning they interact with more protein-bound drugs. This can have implications for drug interactions and the overall effectiveness of the medication.